GSK Pharma to transfer cancer drug portfolio to Novartis arm
GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.
Feb 12, 2015, 21:59 PM IST